Key Takeaway
Most adults lose 8-14% of their body weight on Ozempic over 40-68 weeks. Learn about clinical results, how Ozempic compares to Wegovy, and what factors shape your individual outcome.
Most adults lose approximately 8-14% of their body weight on Ozempic (semaglutide) over 40 to 68 weeks. Clinical trials showed average weight loss of about 9.4-13.8% depending on the dose and study population, though Ozempic is FDA-approved for type 2 diabetes, not weight loss specifically.
What the Data Shows for Ozempic and Weight Loss
Ozempic contains semaglutide, compounded formulations of the active ingredient found in Wegovy. The key difference is dosing: Ozempic is available in 0.5 mg, 1 mg, and 2 mg weekly doses and is FDA-approved for type 2 diabetes, while Wegovy is dosed at up to 2.4 mg weekly and is approved for weight management. Because the maximum Ozempic dose is lower, weight loss tends to be somewhat less than what is seen with Wegovy in clinical trials.
Weight Loss in Diabetes Trials (SUSTAIN Program)
The SUSTAIN clinical trial program studied Ozempic in patients with type 2 diabetes. Weight loss was measured as a secondary outcome:
- SUSTAIN 1 (Ozempic 0.5 mg and 1 mg vs. placebo): Participants lost an average of 8.0 pounds (0.5 mg) and 10.6 pounds (1 mg) over 30 weeks.
- SUSTAIN 2 (vs. sitagliptin): Ozempic 1 mg produced an average weight loss of 13.7 pounds over 56 weeks.
- SUSTAIN 7 (vs. dulaglutide): Ozempic 1 mg produced an average weight loss of 11.5 pounds over 40 weeks.
- SUSTAIN FORTE (2 mg dose): The 2 mg dose produced an average weight loss of about 14.3 pounds over 40 weeks in patients with type 2 diabetes.
Weight Loss When Used Off-Label for Obesity
Many physicians prescribe Ozempic off-label for weight management in patients without diabetes, particularly when Wegovy is unavailable due to supply constraints. Real-world data and clinical experience suggest that Ozempic at the 2 mg dose produces weight loss in the range of 10-14% of body weight when combined with lifestyle changes, which is somewhat less than the 15% seen with Wegovy's 2.4 mg dose.
The STEP 2 trial[1], which used the weight-management formulation of semaglutide (2.4 mg) in patients with type 2 diabetes, showed 9.6% average weight loss. This gives a useful benchmark for what semaglutide can achieve in the diabetes[1] population, even at the higher dose.
What That Looks Like in Pounds
Using the approximate range of 8-14% body weight loss on Ozempic:
- A person starting at 200 pounds might lose roughly 16-28 pounds
- A person starting at 250 pounds might lose roughly 20-35 pounds
- A person starting at 300 pounds might lose roughly 24-42 pounds
Weight Loss Timeline on Ozempic
Ozempic follows a dose titration schedule:
- Weeks 1-4 (0.25 mg): This is a sub-therapeutic dose intended to reduce GI side effects. Weight loss is minimal, typically 1-3 pounds.
- Weeks 5-8 (0.5 mg): Weight loss begins to become noticeable, often 3-5 pounds total by this point.
- Weeks 9+ (1 mg or 2 mg): Weight loss accelerates at the higher therapeutic doses. Most visible progress occurs between months 3 and 10.
- 6-12 months: Weight loss gradually plateaus as the body reaches a new equilibrium.
Factors That Affect Weight Loss on Ozempic
- Dose: The 2 mg dose produces more weight loss than the 1 mg dose, which in turn produces more than 0.5 mg. Your physician will titrate based on tolerance and response.
- Diabetes status: Patients with type 2 diabetes typically lose less weight on semaglutide than those without diabetes, likely due to insulin resistance and other metabolic factors.
- Diet and physical activity: Ozempic reduces appetite, but the food choices you make and your activity level still significantly influence total weight loss.
- Concurrent medications: Some diabetes medications (insulin, sulfonylureas) can promote weight gain and partially offset the weight loss effects of Ozempic.
- Individual variation: Genetic factors, baseline metabolic rate, and gut hormone sensitivity all contribute to how strongly you respond to semaglutide.
What to Consider
Ozempic isn't FDA-approved for weight loss. It's prescribed off-label for that purpose when a physician determines it's appropriate. Wegovy (semaglutide 2.4 mg) is the FDA-approved weight management formulation, and it tends to produce greater weight loss due to the higher dose. If your primary goal is weight loss and you don't have type 2 diabetes, discuss with your physician whether Wegovy or another approved option may be more appropriate. For a complete cost breakdown, see our semaglutide pricing comparison.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Weight loss results from clinical trials were achieved in combination with lifestyle modifications, including dietary changes and increased physical activity. Ozempic alone, without behavioral changes, will likely produce less weight loss than seen in the studies.
As with all GLP-1 medications, weight regain is common after stopping Ozempic. A long-term treatment strategy should be part of your initial discussion with your prescribing physician.
Frequently Asked Questions
Can I take How Much Weight Will I with other medications?
Drug interactions vary depending on the specific medications involved. Always disclose your full medication list to your prescribing provider. Some oral medications may need timing adjustments since GLP-1s can affect gastric emptying.
Do I need a prescription for How Much Weight Will I?
Yes, GLP-1 receptor agonists require a prescription from a licensed healthcare provider. You can obtain a prescription through an in-person visit or a telehealth consultation with a qualified provider.
What are the most common side effects of How Much Weight Will I?
The most frequently reported side effects include nausea (especially during dose escalation), decreased appetite, and mild gastrointestinal discomfort. These typically improve as your body adjusts to the medication over 2-4 weeks.
Medical References
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
Get Started with Physician-Supervised GLP-1 Therapy
FormBlends offers telehealth consultations with licensed physicians who can evaluate whether semaglutide is the right choice for your weight management goals. Every plan includes medical assessment, personalized dosing, and ongoing monitoring. Start your consultation today.